Institut Curie;ONXEO;Centre National de la Recherche Scientifique
发明人:
SUN, JIAN-SHENG,DUTREIX, MARIE,QUANZ-SCHOEFFEL, MARIA
申请号：
PL16183451
公开号：
PL3135301T3
申请日:
2011.06.21
申请国别(地区):
PL
年份:
2018
代理人:
摘要：
The present invention relates to an optimized in vivo delivery system with endosomolytic agents for nucleic acid of therapeutic interest conjugated to molecules facilitating endocytosis, in particular for use in the treatment of cancer.
